Repurposing the Antiviral Drug, Valganciclovir to Treat Cytomegalovirus-Induced Hearing Loss
|Effective start/end date||10/1/21 → 6/30/24|
- THE UNIVERSITY OF UTAH
- CURES WITHIN REACH
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.